T. Rowe Price Associates
NHI icon

T. Rowe Price Associates’s National Health Investors NHI Stock Holding History

T. Rowe Price Associates’s Portfolio NHI Stock Details NHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.27M Buy
52,763
+8,708
+20% +$725K ﹤0.01% 1486
2025
Q4 		$3.37M Buy
44,055
+2,313
+6% +$177K ﹤0.01% 1533
2025
Q3 		$3.32M Buy
41,742
+2,273
+6% +$170K ﹤0.01% 1532
2025
Q2 		$2.77M Buy
39,469
+3,903
+11% +$286K ﹤0.01% 1504
2025
Q1 		$2.63M Buy
35,566
+3,527
+11% +$249K ﹤0.01% 1494
2024
Q4 		$2.22M Buy
32,039
+3,520
+12% +$268K ﹤0.01% 1599
2024
Q3 		$2.4M Buy
28,519
+331
+1% +$25.5K ﹤0.01% 1554
2024
Q2 		$1.91M Buy
28,188
+1,352
+5% +$86.7K ﹤0.01% 1574
2024
Q1 		$1.69M Buy
26,836
+1,516
+6% +$85.5K ﹤0.01% 1657
2023
Q4 		$1.42M Buy
25,320
+910
+4% +$48.2K ﹤0.01% 1703
2023
Q3 		$1.25M Buy
24,410
+997
+4% +$52.2K ﹤0.01% 1699
2023
Q2 		$1.23M Buy
23,413
+1,321
+6% +$68.1K ﹤0.01% 1697
2023
Q1 		$1.14M Buy
22,092
+1,935
+10% +$106K ﹤0.01% 1723
2022
Q4 		$1.05M Buy
20,157
+2,149
+12% +$118K ﹤0.01% 1750
2022
Q3 		$1.02M Buy
18,008
+1,872
+12% +$118K ﹤0.01% 1741
2022
Q2 		$978K Sell
16,136
-13,966
-46% -$795K ﹤0.01% 1905
2022
Q1 		$1.78M Buy
30,102
+5,062
+20% +$288K ﹤0.01% 1735
2021
Q4 		$1.44M Sell
25,040
-3,366
-12% -$186K ﹤0.01% 1847
2021
Q3 		$1.52M Buy
28,406
+1,192
+4% +$74.5K ﹤0.01% 1846
2021
Q2 		$1.82M Buy
27,214
+1,524
+6% +$106K ﹤0.01% 1777
2021
Q1 		$1.86M Sell
25,690
-470
-2% -$32.8K ﹤0.01% 1758
2020
Q4 		$1.81M Sell
26,160
-2,712
-9% -$172K ﹤0.01% 1676
2020
Q3 		$1.74M Sell
28,872
-3,426
-11% -$212K ﹤0.01% 1593
2020
Q2 		$1.96M Buy
32,298
+2,922
+10% +$161K ﹤0.01% 1540
2020
Q1 		$1.46M Buy
29,376
+451
+2% +$34.2K ﹤0.01% 1579
2019
Q4 		$2.36M Buy
28,925
+14,104
+95% +$1.15M ﹤0.01% 1559
2019
Q3 		$1.22M Sell
14,821
-16,491
-53% -$1.34M ﹤0.01% 1730
2019
Q2 		$2.44M Buy
31,312
+18,799
+150% +$1.46M ﹤0.01% 1536
2019
Q1 		$983K Buy
12,513
+3,960
+46% +$315K ﹤0.01% 1844
2018
Q4 		$646K Buy
8,553
+86
+1% +$6.48K ﹤0.01% 1984
2018
Q3 		$640K Buy
8,467
+144
+2% +$11K ﹤0.01% 2053
2018
Q2 		$613K Buy
8,323
+54
+0.7% +$3.82K ﹤0.01% 2053
2018
Q1 		$556K Buy
8,269
+76
+0.9% +$5.19K ﹤0.01% 2048
2017
Q4 		$618K Sell
8,193
-10
-0.1% -$776 ﹤0.01% 2003
2017
Q3 		$634K Hold
8,203
– – ﹤0.01% 1993
2017
Q2 		$650K Buy
8,203
+10
+0.1% +$756 ﹤0.01% 1959
2017
Q1 		$595K Hold
8,193
– – ﹤0.01% 1994
2016
Q4 		$608K Hold
8,193
– – ﹤0.01% 1977
2016
Q3 		$643K Sell
8,193
-13
-0.2% -$1.02K ﹤0.01% 1913
2016
Q2 		$616K Sell
8,206
-4,184
-34% -$290K ﹤0.01% 1884
2016
Q1 		$824K Buy
12,390
+4,400
+55% +$272K ﹤0.01% 1773
2015
Q4 		$486K Buy
7,990
+100
+1% +$5.96K ﹤0.01% 1976
2015
Q3 		$454K Hold
7,890
– – ﹤0.01% 1995
2015
Q2 		$492K Hold
7,890
– – ﹤0.01% 2012
2015
Q1 		$560K Buy
7,890
+1,100
+16% +$79.4K ﹤0.01% 1932
2014
Q4 		$475K Buy
6,790
+300
+5% +$19.5K ﹤0.01% 1977
2014
Q3 		$371K Hold
6,490
– – ﹤0.01% 2063
2014
Q2 		$406K Hold
6,490
– – ﹤0.01% 2037
2014
Q1 		$392K Hold
6,490
– – ﹤0.01% 2022
2013
Q4 		$364K Hold
6,490
– – ﹤0.01% 2052
2013
Q3 		$369K Hold
6,490
– – ﹤0.01% 2012
2013
Q2 		$388K Buy
+6,490
New +$420K ﹤0.01% 1969

Other funds holding NHI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

T. Rowe Price Associates's NHI Position: Q1 2026 in Review

T. Rowe Price Associates increased its National Health Investors (NHI) stake by 20% in Q1 2026, buying an estimated $725K and bringing the position to 52,763 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

T. Rowe Price Associates first reported a position in NHI in Q2 2013 and has held it in 52 quarters since. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.

  • T. Rowe Price Associates held 52,763 shares of National Health Investors worth $4.27M as of Q1 2026.
  • T. Rowe Price Associates bought 8,708 National Health Investors shares in Q1 2026, an estimated $725K.
  • National Health Investors made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1486 holding.
  • T. Rowe Price Associates first reported a position in National Health Investors in Q2 2013 and has held it in 52 quarters since.
  • 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.